Featured Articles
-
Driving Patient Engagement In Medicine Development And Decision-Making: Challenges And Opportunities
6/17/2022
Learn why the shift toward patient-centric, patient-empowered healthcare and decision-making has highlighted gaps in the current process, where patients are the lowest in the chain of command during drug development.
-
4 Ways A CCMS Can Help Medical Affairs Achieve Global Content Reuse And Omnichannel Delivery
6/2/2022
How does a component content management system (CCMS) facilitate content reuse for global omnichannel delivery? This blog tackles what content reuse means in this context.
-
Leveraging Artificial Intelligence (AI) In Pharmacovigilance
5/26/2022
Organizations are adopting a proactive approach to risk management through AI applications throughout their PV life cycle, from case intake to reporting. Learn about the two main categories for leveraging AI in PV processes and their benefits in this blog.
-
The Evolving Machine Translation And Translation Memory Landscape For Life Sciences
5/26/2022
To better understand language technology tools and their benefits, learn why it’s important to understand how the landscape has evolved since they were first introduced, as well as considerations to take into account when deciding on a translation technology partner.
-
Understanding The Scope And Pain Points Of Study Start-Up Part 1: The Site And CRO Perspective
5/24/2022
In this series of webinars, experts will highlight the difficulties behind study start-up and provide solutions to those pain points along the way.
-
Top 10 Pharma Company To Reduce Time To Route Safety Cases
5/24/2022
The client’s central team needed support for pharmacovigilance (PV) triaging and routing of medical information cases that required quick response times. Find out the solution and result of this challenge in this case study.
-
Enabling Diversity And Inclusion In Clinical Trials: A CRO And IRB Perspective
4/22/2022
In the first webinar in the series, Amanda Ryan, President of G3 Life Sciences, will speak with Aman Khera, VP, Global Head of Regulatory Strategy at Worldwide Clinical Trials, and Luke Gelinas, Advarra’s IRB Chair and Senior Advisor, about their perspective on diversity in clinical trials.
-
Rethink Your Study Team To Reimagine Your TMF
4/22/2022
While the advantages and disadvantages of outsourcing are frequently debated, this blog discusses how these outsourcing models end up shaping the sponsors who adopt them.
-
TMF 911, What's Your Inspection Readiness Emergency?
4/22/2022
In this blog post, consider another common TMF inspection readiness emergency on the European Medicine Agency's list.
-
What Do You Need To Know About Digital Marketing For Life Sciences In 2022?
4/4/2022
As life sciences marketers navigate this landscape, discover the fundamental elements that are critical to digital marketing success.